KING OF PRUSSIA, PA, August 11, 2025 — United BioSource LLC (UBC), a leading provider of evidence development solutions for the biopharmaceutical industry, today announced it has embarked on a journey to transform its drug safety capabilities through the implementation of the RxLogix pharmacovigilance (PV) reporting platform.
The new PV reporting platform will propel UBC’s delivery of high-impact, insight-driven drug safety services by providing a more comprehensive and sophisticated aggregate reporting solution.
“This isn’t a reporting tool upgrade — it’s a foundational shift,” said Geraldine Aubes, Executive Director and Global Head of Pharmacovigilance at UBC. “We are building the future of PV, where every function, from case intake to analytics, is integrated, scalable, and intelligent.”
Building on the reliability of UBC’s existing PV ecosystem and complementing its current, industry-leading safety database, the new PV reporting platform brings further time efficiencies and reduces regulatory risk. Its capabilities include:
- Enhanced report output templates, drawing on a library of UBC Gold Standard reporting templates, such as cumulative summary tabulations, interval line listings, and blinded SUSAR listings — all compliant with aggregate regulatory reporting requirements.
- Improved accessibility and transparency, as an advanced self-service, user-friendly tool with real-time generation of graphs and visualizations and the ability to schedule recurring reports.
- Faster ad-hoc reporting, enabled by the ability to create custom reports on the fly with less IT support, as well as respond quickly and comprehensively to regulatory or internal queries.
Reducing the need for manual oversight, the new platform enables PV professionals to spend more time on risk evaluation, regulatory strategy, and patient-centric insights. This initiative sets the stage for additional safety reporting enhancements in the future.
About UBC
United BioSource LLC (UBC) is the leading provider of evidence development solutions with expertise in uniting evidence and access. UBC helps biopharma mitigate risk, address product hurdles, and demonstrate safety, efficacy, and value under real-world conditions. Underpinned by our scientific expertise, data and analytics, and innovative technologies, we offer our customers flexible solutions generating the relevant real-world data necessary to make more informed decisions earlier, meet stakeholder requirements, and, ultimately, drive better patient outcomes. For additional information, visit www.ubc.com.
About RxLogix Corporation
RxLogix is a global pharmacovigilance solutions company specializing in innovative software and expert consulting services. Our talented team of business and technology innovators works with Pharmacovigilance and Risk Management Professionals to help increase the compliance, productivity, and quality for the entire Drug Safety value chain. We are business transformers, digital thinkers, tech Innovators, technology revolutionists, business mavericks, driven and open-minded individuals. At RxLogix, our goal is to make the most innovative industry standard software for the life sciences domain. For additional information, visit www.rxlogix.com.
